CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update
Written by Janine McCargo on November 9, 2017
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time…
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time…
Berkeley Heights, NJ – November 9, 2017 – CorMedix Inc….
Berkeley Heights, NJ – October 26, 2017 – CorMedix Inc….
Gary Gelbfish, M.D. Appointed as Observer to the Company’s Board…
Conference Call and Webcast to be held Friday, March 17,…
Bedminster, NJ – March 2, 2017 – CorMedix Inc. (NYSE…
Robert W. Cook, International Biopharma Finance Expert, Appointed Chief Financial…
Bedminster, NJ – January 9, 2017 – CorMedix Inc. (NYSE…
Bedminster, NJ – January 5, 2017 – CorMedix Inc. (NYSE…
Bedminster, NJ – December 21, 2016 – CorMedix Inc. (NYSE…
Bedminster, NJ – November 30, 2016 – CorMedix Inc. (NYSE…
Conference Call Today at 4:30 p.m. Eastern Time Bedminster,…
Conference Call to be held Thursday, November 10, 2016, at…
Bedminster, NJ – October 3, 2016 – CorMedix Inc. (NYSE…
Bedminster, NJ –September 20, 2016 – CorMedix Inc. (NYSE MKT:…
Bedminster, NJ – December 14, 2015 – CorMedix Inc. (NYSE…
Company to Host Conference Call at 9 am on Friday,…
BEDMINSTER, NJ / ACCESSWIRE / October 5, 2015 / CorMedix…
BEDMINSTER, NJ–September 24, 2015–CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical…
BEDMINSTER, NJ–August 31, 2015–CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical…